semaglutide anaesthesia Pulmonary aspiration of gastric contents in two patients taking for weight loss - Avraham - 2024 - Reports Aspiration precautions for diabetes and

Why can weight loss progress vary between women taking the same GLP-1 dose

January 31, 2025.

Warning over 'unlicensed' nasal tanning sprays Trading Standards has issued a warning about nasal tanning sprays and the potential health problems they could cause people who have used them

Those treated with Wegovy, whose active ingredient is semaglutide, experienced a reduction in major cardiac events by up to 28%, and saw a 24% reduction in the risk of cardiac-related death and a 19% reduction in the risk of death from any cause

The strong clinical success of semaglutide-based therapies in diabetes and obesity management has generated substantial interest among biosimilar developers